Eagle Equity Partners III, LLC

Insider

First SEC filing: Feb. 23, 2021 · Latest: Feb. 23, 2021

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Sept. 16, 2021	DNA	D	1,925,000	—	—	17,325,000 Direct	-10.00%	Disposed	(price as of 2026-08-21)
Sept. 16, 2021	DNA	A	19,250,000	$10.00	$192,500,000	19,250,000 Direct	—	Acquired	-98.3% (price as of 2026-08-21)
Sept. 16, 2021	DNA	M	43,125,000	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-21)
Sept. 16, 2021	DNA	D	11,534,052	—	—	31,590,948 Direct	-26.75%	Disposed	(price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Sept. 16, 2021	DNA	Private Placement Warrants	Class A Common Stock (1,925,000)	$11.50	—	1,925,000	Disposed
Sept. 16, 2021	DNA	Private Placement Warrants	Class A Common Stock (19,250,000)	$11.50	—	19,250,000	Acquired
Sept. 16, 2021	DNA	Class B Ordinary Shares	Class A Common Stock (43,125,000)	—	—	43,125,000	Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Feb. 23, 2021	DNA	Class B Ordinary Shares→ Class A Ordinary Shares (43,125,000)	43,125,000	Direct